Ad is loading...
JEMGX
Price
$9.52
Change
-$0.06 (-0.63%)
Updated
Nov 15 closing price
RNWEX
Price
$79.58
Change
-$0.79 (-0.98%)
Updated
Nov 15 closing price
Ad is loading...

JEMGX vs RNWEX

Header iconJEMGX vs RNWEX Comparison
Open Charts JEMGX vs RNWEXBanner chart's image
JHancock Emerging Markets Equity R6
Price$9.52
Change-$0.06 (-0.63%)
VolumeN/A
CapitalizationN/A
American Funds New World R4
Price$79.58
Change-$0.79 (-0.98%)
VolumeN/A
CapitalizationN/A
JEMGX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEMGX vs. RNWEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEMGX is a Buy and RNWEX is a Buy.

FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 60.9B vs. JEMGX (1.44B). JEMGX pays higher dividends than RNWEX: JEMGX (1.63) vs RNWEX (1.24). JEMGX was incepted earlier than RNWEX: JEMGX (9 years) vs RNWEX (22 years). JEMGX is a more actively managed with annual turnover of: 37.00 vs. RNWEX (32.00). RNWEX has a lower initial minimum investment than JEMGX: RNWEX (250) vs JEMGX (1000000). RNWEX annual gain was more profitable for investors over the last year : 11.20 vs. JEMGX (9.16). RNWEX return over 5 years is better than : 16.22 vs. JEMGX (-10.06).
JEMGXRNWEXJEMGX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD5.4266.81980%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B60.9B2%
Annual Yield % from dividends1.631.24131%
Returns for 1 year9.1611.2082%
Returns for 3 years-33.08-15.12219%
Returns for 5 years-10.0616.22-62%
Returns for 10 yearsN/A39.20-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVC2.57-0.01
-0.39%
Entravision Communication
DPZ430.43-5.54
-1.27%
Domino's Pizza
KPRX3.29-0.11
-3.15%
Kiora Pharmaceuticals Inc.
FORM37.80-1.89
-4.76%
FormFactor
PRTA14.01-2.09
-12.98%
Prothena Corp